257. 肝型糖原病 Hepatic glycogenosis Clinical trials / Disease details

臨床試験数 : 14 / 薬物数 : 27 - (DrugBank : 7) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 8

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04930627 (ClinicalTrials.gov)	July 2021	11/6/2021	Safety and Efficacy of Empagliflozin in GSD1b Patients With Neutropenia	Evaluation of Efficacy and Safety of Empagliflozinin Treatment of Neutropenia in Patients With Glyco ...	Glucose 6 Phosphatase Deficiency	Drug: Empagliflozin	Children's Memorial Health Institute, Poland	Department of Internal Medicine, Hypertension and Vascular Diseases, The Medical University of Warsa ...	Not yet recruiting	N/A	N/A	All	20	Phase 2	Poland
2	NCT04138251 (ClinicalTrials.gov)	June 20, 2019	20/6/2019	Safety, Efficacy Evaluation of EmpagliflozinAdministration for Neutropenia in Glycogenosis Type 1b a ...	Evaluation of the Safety and Efficacy of EmpagliflozinAdministration as a Treatment for Neutropenia ...	Glycogen Storage Disease Type I;Glucose 6 Phosphatase Deficiency	Drug: Empagliflozin	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	NULL	Recruiting	1 Year	18 Years	All	5	Phase 2	Belgium

First Previous1Next Last